Trialjectory is a patient first tech start-up using AI to clinically match cancer patients to clinical trials. Our mission is to democratize access to advanced cancer treatment – specifically the 85% of patients being treated in a community hospital setting. With over 50,000 cancer patients helped, and a monthly community growth rate of 15%+, Trialjectory has been recognized by TIME as one of “The 100 Best Inventions of 2020” and named an honoree in the AI and data category for Fast Company’s “2021 World-Changing Ideas Awards."
Learn more at https://www.trialjectory.com/?refid=forum
